Matches in Nanopublications for { ?s ?p "[The EPO level was significantly higher in the thalassemic patients (54.8mU/ml in HbH disease [? thal1/? thal2;], 78.1mU/ml in HbH with Hb CS [? thal 1/CS]; 95.6mU/ml in ?-thal/HbE splenectomized [BE(S)]; and 114.8mU/ml in ?-thal/HbE non-splenectomized [BE(NS)]as compared with 12.0mU/ml in normal subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- assertion description "[The EPO level was significantly higher in the thalassemic patients (54.8mU/ml in HbH disease [? thal1/? thal2;], 78.1mU/ml in HbH with Hb CS [? thal 1/CS]; 95.6mU/ml in ?-thal/HbE splenectomized [BE(S)]; and 114.8mU/ml in ?-thal/HbE non-splenectomized [BE(NS)]as compared with 12.0mU/ml in normal subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.